Xtant Medical Holdings, Inc. (XTNT) News
Filter XTNT News Items
XTNT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest XTNT News From Around the Web
Below are the latest news stories about XTANT MEDICAL HOLDINGS INC that investors may wish to consider to help them evaluate XTNT as an investment opportunity.
Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics BusinessBELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it completed the acquisition of certain assets and liabilities related to the domestic and international biologics and spinal fixation offerings of Surgalign Holdings, Inc. under a Bankruptcy Court supervised process for $5 million, plus assumed liabilities, in an all-ca |
Q2 2023 Xtant Medical Holdings Inc Earnings CallQ2 2023 Xtant Medical Holdings Inc Earnings Call |
Xtant Medical Announces Second Quarter Revenue Growth of 32%Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2023. “In the second quarter, we achieved strong revenue growth on both a sequential and annual basis driven by our core biologics and fixatio |
Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics BusinessAcquisition to Enhance Xtant’s Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it was the successful bidder for certain assets and liabilities related to the domestic and international biologics and spinal fixation offerings of Surgalign Holdings, Inc. Xtant’s initial bid, as se |
Xtant Medical to Issue Second Quarter 2023 Financial Results on August 1, 2023BELGRADE, Mont., July 25, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2023, before the open of the financial markets on Tuesday, August 1, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference cal |
Xtant Medical Announces Closing of $15 Million Private PlacementBELGRADE, Mont., July 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of its previously announced $15 million private placement with accredited investors. The Company sold 20 million shares of common stock at a purchase price of $0.75 per share. After deducting fees and other estimated offering expenses, the Company received net pro |
Xtant Medical Announces $15 Million Private PlacementBELGRADE, Mont., July 03, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has entered into a securities purchase agreement with accredited investors to sell shares of its common stock in a private placement. The Company agreed to issue an aggregate of 20,000,000 shares of common stock at a purchase price of $0.75 per share, resulting in gross pr |
Xtant Medical Appoints Lori Mitchell-Keller to Board of DirectorsBELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Lori Mitchell-Keller to the Company's Board of Directors effective May 16, 2023. Ms. Mitchell-Keller will serve as a member of the Compensation and Audit Committees of the Board of Directors. “We are pleased to welcome Lori to our Board, marking another high |
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2023 Earnings Call TranscriptXtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2023 Earnings Call Transcript May 6, 2023 Operator: Greetings. You’re welcome Xtant Medical’s Q1 2023 financial results call. . As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Matt Steinberg of Lazar FINN Partners. Please go ahead. Matt […] |
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue GuidanceInitiates Annual Revenue Guidance of $73 Million - $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2023. The Company also introduced financial guidance for the full year 2023. “Highlighted by solid revenue growth and the Cofle |